Protein and peptide array analysis of autoimmune disease.
Molecular cloning, sequencing of the human genome, and other major advances in biomedical research have contributed substantially to our understanding of autoimmune disease. Nevertheless, to date, such advances have failed to reveal the etiology of or yield curative therapies for autoimmune disease. New approaches are needed. Proteomics, the large-scale study of expression and function of proteins that compose our tissues and mediate disease, represents a powerful and promising strategy. We developed protein and peptide arrays to profile autoantibody responses in autoimmune disease. Protein and peptide array analysis of autoimmune samples is revealing human and pathogen proteins involved in initiation and perpetuation of autoimmunity. Proteomic determination of autoantibody profiles can be utilized for diagnosis, prognostication, and guiding tolerizing therapy for autoimmune disease.
Robinson
William H
WH
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. wrobins@stanford.edu
Steinman
Lawrence
L
Utz
Paul J
PJ
D000941:Antigens / Q000737:chemistry / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis / Q000737:chemistry* / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology* / Q000378:metabolism*; D001402:B-Lymphocytes / Q000276:immunology; D006801:Humans; D040081:Protein Array Analysis / Q000295:instrumentation / Q000379:methods*; D040901:Proteomics / Q000295:instrumentation / Q000379:methods; D013601:T-Lymphocytes / Q000276:immunology
D000941:Antigens; D001323:Autoantibodies